Trial Profile
Efficacy and Safety of Nivestim in peripheral blood stem cell mobilization for harvesting and haematopoietic stem cell transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Jul 2017
Price :
$35
*
At a glance
- Drugs Filgrastim (Primary)
- Indications Febrile neutropenia; Neutropenia
- Focus Therapeutic Use
- 20 Jul 2017 New trial record
- 25 Jun 2017 Results presented at the 22nd Congress of the European Haematology Association